DPC Biosciences

DPC Biosciences Corporation, formerly known as Neuro-Biotech Corporation, was a Canadian biotechnology company based in Montreal, Quebec, that specialized in the research and development of pharmaceutical and diagnostic products for neurological conditions. The company focused on the neuro-psycho-endocrine and immune systems, aiming to provide early diagnosis and targeted therapeutic approaches for major neurological diseases. Publicly traded on the TSX Venture Exchange under the symbol DPC.H, the company was active in the early 2000s before undergoing a significant strategic shift. In 2006, DPC Biosciences announced a 'Change of Business,' pivoting its operations from the life sciences sector to the online gaming industry, which eventually led to its delisting from the exchange.